Market Research Reports and Industry Reports

Europe Anti-Obesity Drug Market Report 2016

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Notes:
Sales, means the sales volume of Anti-Obesity Drug
Revenue, means the sales value of Anti-Obesity Drug

This report studies sales (consumption) of Anti-Obesity Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Anti-Obesity Drug in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on sales, market share and growth rate of Anti-Obesity Drug in each application, can be divided into
Application 1
Application 2
Application 3



Europe Anti-Obesity Drug Market Report 2016
1 Anti-Obesity Drug Overview
1.1 Product Overview and Scope of Anti-Obesity Drug
1.2 Classification of Anti-Obesity Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Anti-Obesity Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Anti-Obesity Drug Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Anti-Obesity Drug (2011-2021)
1.5.1 Europe Anti-Obesity Drug Sales and Growth Rate (2011-2021)
1.5.2 Europe Anti-Obesity Drug Revenue and Growth Rate (2011-2021)

2 Europe Anti-Obesity Drug by Manufacturers, Type and Application
2.1 Europe Anti-Obesity Drug Market Competition by Manufacturers
2.1.1 Europe Anti-Obesity Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Anti-Obesity Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Anti-Obesity Drug (Volume and Value) by Type
2.2.1 Europe Anti-Obesity Drug Sales and Market Share by Type (2011-2016)
2.2.2 Europe Anti-Obesity Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Anti-Obesity Drug (Volume and Value) by Countries
2.3.1 Europe Anti-Obesity Drug Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Anti-Obesity Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Anti-Obesity Drug (Volume) by Application

3 Germany Anti-Obesity Drug (Volume, Value and Sales Price)
3.1 Germany Anti-Obesity Drug Sales and Value (2011-2016)
3.1.1 Germany Anti-Obesity Drug Sales and Growth Rate (2011-2016)
3.1.2 Germany Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
3.1.3 Germany Anti-Obesity Drug Sales Price Trend (2011-2016)
3.2 Germany Anti-Obesity Drug Sales and Market Share by Manufacturers
3.3 Germany Anti-Obesity Drug Sales and Market Share by Type
3.4 Germany Anti-Obesity Drug Sales and Market Share by Application

4 France Anti-Obesity Drug (Volume, Value and Sales Price)
4.1 France Anti-Obesity Drug Sales and Value (2011-2016)
4.1.1 France Anti-Obesity Drug Sales and Growth Rate (2011-2016)
4.1.2 France Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
4.1.4 France Anti-Obesity Drug Sales Price Trend (2011-2016)
4.2 France Anti-Obesity Drug Sales and Market Share by Manufacturers
4.3 France Anti-Obesity Drug Sales and Market Share by Type
4.4 France Anti-Obesity Drug Sales and Market Share by Application

5 UK Anti-Obesity Drug (Volume, Value and Sales Price)
5.1 UK Anti-Obesity Drug Sales and Value (2011-2016)
5.1.1 UK Anti-Obesity Drug Sales and Growth Rate (2011-2016)
5.1.2 UK Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
5.1.5 UK Anti-Obesity Drug Sales Price Trend (2011-2016)
5.2 UK Anti-Obesity Drug Sales and Market Share by Manufacturers
5.3 UK Anti-Obesity Drug Sales and Market Share by Type
5.4 UK Anti-Obesity Drug Sales and Market Share by Application

6 Russia Anti-Obesity Drug (Volume, Value and Sales Price)
6.1 Russia Anti-Obesity Drug Sales and Value (2011-2016)
6.1.1 Russia Anti-Obesity Drug Sales and Growth Rate (2011-2016)
6.1.2 Russia Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
6.1.6 Russia Anti-Obesity Drug Sales Price Trend (2011-2016)
6.2 Russia Anti-Obesity Drug Sales and Market Share by Manufacturers
6.3 Russia Anti-Obesity Drug Sales and Market Share by Type
6.4 Russia Anti-Obesity Drug Sales and Market Share by Application

7 Italy Anti-Obesity Drug (Volume, Value and Sales Price)
7.1 Italy Anti-Obesity Drug Sales and Value (2011-2016)
7.1.1 Italy Anti-Obesity Drug Sales and Growth Rate (2011-2016)
7.1.2 Italy Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
7.1.7 Italy Anti-Obesity Drug Sales Price Trend (2011-2016)
7.2 Italy Anti-Obesity Drug Sales and Market Share by Manufacturers
7.3 Italy Anti-Obesity Drug Sales and Market Share by Type
7.4 Italy Anti-Obesity Drug Sales and Market Share by Application

8 Spain Anti-Obesity Drug (Volume, Value and Sales Price)
8.1 Spain Anti-Obesity Drug Sales and Value (2011-2016)
8.1.1 Spain Anti-Obesity Drug Sales and Growth Rate (2011-2016)
8.1.2 Spain Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
8.1.8 Spain Anti-Obesity Drug Sales Price Trend (2011-2016)
8.2 Spain Anti-Obesity Drug Sales and Market Share by Manufacturers
8.3 Spain Anti-Obesity Drug Sales and Market Share by Type
8.4 Spain Anti-Obesity Drug Sales and Market Share by Application

9 Benelux Anti-Obesity Drug (Volume, Value and Sales Price)
9.1 Benelux Anti-Obesity Drug Sales and Value (2011-2016)
9.1.1 Benelux Anti-Obesity Drug Sales and Growth Rate (2011-2016)
9.1.2 Benelux Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Anti-Obesity Drug Sales Price Trend (2011-2016)
9.2 Benelux Anti-Obesity Drug Sales and Market Share by Manufacturers
9.3 Benelux Anti-Obesity Drug Sales and Market Share by Type
9.4 Benelux Anti-Obesity Drug Sales and Market Share by Application

10 Europe Anti-Obesity Drug Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Anti-Obesity Drug Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Pfizer Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Merck
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Anti-Obesity Drug Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Merck Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 F. Hoffmann-La Roche
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Anti-Obesity Drug Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 F. Hoffmann-La Roche Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Anti-Obesity Drug Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 GlaxoSmithKline Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 AstraZeneca
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Anti-Obesity Drug Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 AstraZeneca Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Boehringer Ingelheim
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Anti-Obesity Drug Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Boehringer Ingelheim Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Anti-Obesity Drug Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Novo Nordisk Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Eisai
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Anti-Obesity Drug Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Eisai Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Norgine
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Anti-Obesity Drug Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Norgine Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Arena Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti-Obesity Drug Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Arena Pharmaceuticals Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Orexigen Therapeutics
10.12 Vivus
10.13 Alizyme
10.14 Rhythm Pharmaceuticals
10.15 Shionogi
10.16 Zafgan

11 Anti-Obesity Drug Manufacturing Cost Analysis
11.1 Anti-Obesity Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anti-Obesity Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Anti-Obesity Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anti-Obesity Drug Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Anti-Obesity Drug Market Forecast (2016-2021)
14.1 Germany Anti-Obesity Drug Sales Forecast (2016-2021)
14.2 France Anti-Obesity Drug Sales Forecast (2016-2021)
14.3 UK Anti-Obesity Drug Sales Forecast (2016-2021)
14.4 Russia Anti-Obesity Drug Sales Forecast (2016-2021)
14.5 Italy Anti-Obesity Drug Sales Forecast (2016-2021)
14.6 Spain Anti-Obesity Drug Sales Forecast (2016-2021)
14.7 Benelux Anti-Obesity Drug Sales Forecast (2016-2021)
14.8 Europe Anti-Obesity Drug Sales Forecast by Type (2016-2021)
14.9 Europe Anti-Obesity Drug Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer



List Of Tables

List of Tables and Figures

Figure Picture of Anti-Obesity Drug
Table Classification of Anti-Obesity Drug
Figure Europe Sales Market Share of Anti-Obesity Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Anti-Obesity Drug
Figure Europe Sales Market Share of Anti-Obesity Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure France Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure UK Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Russia Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Italy Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Spain Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Europe Anti-Obesity Drug Sales and Growth Rate (2011-2021)
Figure Europe Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Table Europe Anti-Obesity Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Anti-Obesity Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Obesity Drug Sales Share by Manufacturers
Figure 2016 Anti-Obesity Drug Sales Share by Manufacturers
Table Europe Anti-Obesity Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Anti-Obesity Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Anti-Obesity Drug Revenue Share by Manufacturers
Table 2016 Europe Anti-Obesity Drug Revenue Share by Manufacturers
Table Europe Anti-Obesity Drug Sales and Market Share by Type (2011-2016)
Table Europe Anti-Obesity Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Anti-Obesity Drug by Type (2011-2016)
Figure Europe Anti-Obesity Drug Sales Growth Rate by Type (2011-2016)
Table Europe Anti-Obesity Drug Revenue and Market Share by Type (2011-2016)
Table Europe Anti-Obesity Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti-Obesity Drug by Type (2011-2016)
Figure Europe Anti-Obesity Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Anti-Obesity Drug Sales and Market Share by Countries (2011-2016)
Table Europe Anti-Obesity Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Anti-Obesity Drug by Countries (2011-2016)
Table Europe Anti-Obesity Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Anti-Obesity Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Anti-Obesity Drug by Countries (2011-2016)
Table Europe Anti-Obesity Drug Sales and Market Share by Application (2011-2016)
Table Europe Anti-Obesity Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Anti-Obesity Drug by Application (2011-2016)
Figure Germany Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Germany Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Germany Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Germany Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Germany Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Germany Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Germany Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Germany Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure France Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure France Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure France Anti-Obesity Drug Sales Price Trend (2011-2016)
Table France Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table France Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table France Anti-Obesity Drug Sales by Type (2015 and 2016)
Table France Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table France Anti-Obesity Drug Sales by Application (2015 and 2016)
Table France Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure UK Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure UK Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure UK Anti-Obesity Drug Sales Price Trend (2011-2016)
Table UK Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table UK Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table UK Anti-Obesity Drug Sales by Type (2015 and 2016)
Table UK Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table UK Anti-Obesity Drug Sales by Application (2015 and 2016)
Table UK Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Russia Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Russia Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Russia Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Russia Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Russia Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Russia Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Russia Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Russia Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Italy Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Italy Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Italy Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Italy Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Italy Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Italy Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Italy Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Italy Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Spain Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Spain Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Spain Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Spain Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Spain Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Spain Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Spain Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Spain Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Benelux Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Benelux Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Benelux Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Benelux Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Benelux Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Benelux Anti-Obesity Drug Market Share by Application (2015 and 2016)
Table Anti-Obesity Drug Basic Information List
Table Pfizer Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti-Obesity Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anti-Obesity Drug Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Anti-Obesity Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Anti-Obesity Drug Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Anti-Obesity Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Anti-Obesity Drug Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Anti-Obesity Drug Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Anti-Obesity Drug Sales Market Share (2011-2016)
Table Norgine Basic Information List
Table Norgine Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Norgine Anti-Obesity Drug Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Anti-Obesity Drug Sales Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information List
Table Orexigen Therapeutics Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexigen Therapeutics Anti-Obesity Drug Sales Market Share (2011-2016)
Table Vivus Basic Information List
Table Vivus Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vivus Anti-Obesity Drug Sales Market Share (2011-2016)
Table Alizyme Basic Information List
Table Alizyme Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alizyme Anti-Obesity Drug Sales Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rhythm Pharmaceuticals Anti-Obesity Drug Sales Market Share (2011-2016)
Table Shionogi Basic Information List
Table Shionogi Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shionogi Anti-Obesity Drug Sales Market Share (2011-2016)
Table Zafgan Basic Information List
Table Zafgan Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zafgan Anti-Obesity Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drug
Figure Manufacturing Process Analysis of Anti-Obesity Drug
Figure Anti-Obesity Drug Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drug Major Manufacturers in 2015
Table Major Buyers of Anti-Obesity Drug
Table Distributors/Traders List
Figure Germany Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Anti-Obesity Drug Sales Forecast by Type (2016-2021)
Table Europe Anti-Obesity Drug Sales Forecast by Application (2016-2021)

EMEA (Europe, Middle East and Africa) X-Ray Real-Time Image System Market Report 2017

In this report, the EMEA X-Ray Real-Time Image System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

USD 4000View Report

EMEA (Europe, Middle East and Africa) X-Ray Flaw Detector Market Report 2017

In this report, the EMEA X-Ray Flaw Detector market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

USD 4000View Report

EMEA (Europe, Middle East and Africa) X Ray Machine Market Report 2017

In this report, the EMEA X Ray Machine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

USD 4000View Report

Anti-Obesity Drugs Industry Forecasts - China Focus

This study focuses on Chinas Anti-Obesity Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the

USD 1800View Report

United States Anti-Obesity Drugs Market Report 2017

Notes:Sales, means the sales volume of Anti-Obesity DrugsRevenue, means the sales value of Anti-Obesity DrugsThis report studies sales (consumption) of Anti-Obesity Drugs in United States market, focuses on the top

USD 3800View Report

Global Anti-Obesity Drugs Industry 2016 Market Research Report

Global Anti-Obesity Drugs Industry 2016 Market Research Report was a professional and depth research report on Global Anti-Obesity Drugs industry that you would know the worlds major regional market conditions

USD 2850View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 3900
  • Global Licence    $ 7800
$ 3900

Reports Details

Published Date : Oct 2016
No. of Pages :111
Country :Europe
Category :Pharmaceuticals and Healthcare
Publisher :QYResearch Group
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube